Fox Chase Cancer Center News

PHILADELPHIA, (October 14, 2021)—Fox Chase Cancer Center researcher Alfonso Bellacosa, MD, PhD, was recently named a recipient of the first ever 2021 Mid-Atlantic Italian American Medical Awards.

PHILADELPHIA (October 14, 2021)—Cristina Uribe-Alvarez, PhD, a postdoctoral associate in the lab of Jonathan Chernoff, MD, PhD, at Fox Chase Cancer Center recently received a $75,000 one-year grant from the F.M. Kirby Foundation to continue her study on RAC1 mutations in melanoma.

PHILADELPHIA (October 14, 2021)—A recent study by Fox Chase Cancer Center scientists provides new insight into the mechanism that controls DNA replication timing (RT), a process that is controlled during development and dysfunctional in diseases such as cancer.

PHILADELPHIA (October 13, 2021)—Gary Barbera’s on the Boulevard, a family owned and operated Dodge, Chrysler, Jeep, and Ram car dealership in Philadelphia, will donate $50 to Fox Chase Cancer Center for every car sold during October as part of their “Kick Cancer to the Curb” program. October is Breast Cancer Awareness Month.

PHILADELPHIA (October 12, 2021)—When people think of global warming and climate change, they tend to think of melting glaciers, rising sea levels, and drought. They do not, however, generally think of obesity and other potential health effects.

PHILADELPHIA (October 6, 2021)—Fox Chase Cancer Center recently welcomed a new class of 21 Biomedical Sciences graduate students from the Lewis Katz School of Medicine at Temple University to introduce them to research faculty with whom they can do scientific rotations and ultimately their thesis research.

PHILADELPHIA (October 6, 2021)—Hossein Borghaei, DO, MS, chief of the Division of Thoracic Medical Oncology at Fox Chase Cancer Center, has been named one of three winners of the second annual Lung Cancer Heroes awards program.

PHILADELPHIA (October 5, 2021)—In a recently published study, a researcher at Fox Chase Cancer Center outlined new methods for handling heterogeneous data types from large-scale studies. These studies generate genomic profiles with the goal of identifying subgroups of patients who may have a better prognosis or benefit from a particular treatment.